Content Type: Article

  • Analyzing Fee Restrictions for Health IT and EHI Under ONC’s Final Information Blocking Rule

    Analyzing Fee Restrictions for Health IT and EHI Under ONC’s Final Information Blocking Rule

    CLIENT ALERT / INFORMATION BLOCKING / INTEROPERABILITY

    Analyzing Fee Restrictions for Health IT and EHI Under ONC’s Final Information Blocking Rule

    March 20, 2020

    Read time: 21 min

    Key takeaways
    Overview

    The Office of the National Coordinator for Health Information Technology recently released a final rule under the 21st Century Cures Act to promote interoperability of health IT and advance access, exchange or use of electronic health information (EHI). The final rule has significant implications for how health IT developers, health care providers and other stakeholders price access to application programming interfaces (APIs) and other technology used to access, exchange or use EHI. This On the Subject discusses the framework for determining whether license fees and other charges for use of such technology would comply with the final rule’s exceptions to the Cures Act’s information blocking prohibition and condition of certification for certified APIs.

    In depth

    On March 9, 2020, the Office of the National Coordinator for Health Information Technology (ONC) released its final rule under the 21st Century Cures Act to implement various policies to promote interoperability of health information technology (IT) and advance access, exchange or use of electronic health information (EHI) for continuity of care and other appropriate purposes. The final rule amends the certification requirements under the ONC Health IT Certification Program and identifies health IT pricing practices that do not fall under the Cures Act’s information blocking prohibition.

    These final policies have significant implications for how certified health IT developers, health care providers, health information networks (HINs) and health information exchanges (HIEs) (collectively, actors) license and charge for technology to enable access, exchange or use of EHI with patients and other technology and service providers, health care providers and health plans.

    Subject to limited exceptions, EHI covered by the information blocking prohibition includes electronic protected health information under the Health Insurance Portability and Accountability Act of 1996 (HIPAA) regulations (EPHI) to the extent that the EPHI is part of a patient’s electronic medical record or another designated record set under HIPAA, regardless of whether the records are used or maintained by or for a HIPAA covered entity. However, until the date 24 months after the publication of the final rule in the Federal Register, EHI is limited to the data elements represented in the US Core Data for Interoperability (USCDI) standard adopted under the health IT certification provisions of the final rule.

    This On the Subject discusses the analytical framework for determining whether license fees and other charges for use of application programing interfaces (APIs) and other technology used to access, exchange or use EHI comply with the final rule’s information blocking exceptions and condition of certification for certified APIs. It also recommends practical next steps for implementing the final rule’s fee restrictions.

    For more information about the final rule, including provisions that are not directly related to fees and other charges, see McDermott’s prior Special Report comprehensively covering the information blocking provisions of the final rule.

    Does the information blocking prohibition restrict charges for health IT used to access, exchange and use EHI?

    The final rule generally defines information blocking to mean a practice by an actor that is likely to interfere with, prevent or materially discourage access, exchange or use of EHI unless the practice is required by law or covered by an exception in the final rule. Because of this broad definition, any fees or other charges that an actor charges patients, health care providers, health plans, technology or service providers or other third parties for access, exchange or use of EHI or technology to enable such access, exchange or use, potentially implicate the information blocking prohibition. Consequently, those fees and charges, unless required by law, would need to fit within an information blocking exception to protect the actor from potential information blocking liability.

    What information blocking exceptions protect licensee fees and other charges for use of health IT used to access, exchange and use EHI?

    The final rule includes the following three exceptions for license fees and other charges for interoperability elements and other fees for use of technology that may interfere with EHI access, exchange or use. A fee or other charge that meets the definition of information blocking must satisfy at least one of these exceptions:

    • Content and Manner Exception
    • Fees Exception
    • Licensing Exception

    Content and Manner Exception

    The Content and Manner Exception allows an actor and a party that requests EHI to negotiate mutually agreeable terms (including fees) for access, exchange and use of EHI. To be protected under the Content and Manner Exception, the actor must respond to a request for EHI with the subset of EHI identified by the USCDI data elements until the date 24 months after the publication of the final rule in the Federal Register. After that date, actors must respond with all EHI in a designated record set as discussed above.

    In terms of the manner of response, an actor must fulfill a request for access, exchange or use of the required content in the manner requested, unless (1) the actor cannot technically fulfill the request, or (2) the actor and requestor are unable to reach mutually agreeable terms. If an actor fulfills a request in the manner requested, the limitations in the Fee Exception and Licensing Exception would not apply. Thus, the actor would have the opportunity to negotiate mutually agreeable fees and other terms with requestors.

    If the actor does not fulfill a request in the requested manner, then the actor must fulfill the request in one of three alternative manners specified in the exception without unnecessary delay. When an actor fulfills a request in an alternative manner, the fees charged would have to meet the Fees Exception or the Licensing Exception.

    Fees Exception

    The Fees Exception allows an actor to charge fees, including those that result in a reasonable profit margin, for accessing, exchanging or using EHI, provided that the fee is:

    • Based on objective and verifiable criteria, uniformly applied for similarly situated people/requests;
    • Reasonably related to the actor’s costs;
    • Reasonably allocated among all similarly situated people; and
    • Based on costs not already recovered for the same instance of the service to a provider or third party.

    In addition, the fee must not be based on:

    • Competitive considerations;
    • Sales, profit, revenue or other value that the requestor or other party may derive from the access, exchange or use of the EHI;
    • Costs that an actor incurs because it designed or implemented health IT in non-standard ways (unless the requestor agreed to the fee associated with such implementation);
    • Costs associated with intangible assets other than actual development and acquisition costs;
    • Opportunity costs unrelated to the access, exchange or use of EHI; or
    • Any costs leading to the creation of intellectual property if the actor charges a royalty for that intellectual property under the Licensing Exception and the royalty includes development costs of creating that intellectual property.

    Additionally, an actor may not charge any of the following fees under the Fees Exception:

    • Fees prohibited under the HIPAA Privacy Rule for individuals’ requests for access to their protected health information;
    • Fees based in any way on the electronic access of an individual’s EHI by the individual, the individual’s personal representatives or others designated by the individual (The final rule defines “electronic access” as “an internet-based method that makes EHI available at the time the EHI is requested and where no manual effort is required to fulfill the request.” So whenever fulfilling individuals’ requests to send EHI to themselves or their personal representatives or others they designate, if the process requires manual effort, such as collating or assembling electronic health records from multiple systems, then the definition of electronic access would not be met and the actor could charge a fee and meet the Fees Exception.);
    • Fees to export EHI to switch health IT or provide EHI to patients, if done through a capability certified to the final rule’s EHI export health IT certification criterion at 45 CFR § 170.315(b)(10) (Certified EHI Export Capability); and
    • Fees to export or convert data from an EHR system, unless the parties agreed to the fee in writing at the time the EHR system was acquired.

    In addition, this exception requires health IT developers that create certified API technology (certified API developers) to comply with the new condition of certification for certified APIs as a condition of meeting the Fees Exception.

    Licensing Exception

    Under the Licensing Exception, an actor’s terms (including those related to fees) for licensing an interoperability element for EHI to be accessed, exchanged or used is not prohibited information blocking when the practice meets all of the conditions discussed below. The final rule defines the term “interoperability element” to mean “hardware, software, integrated technologies or related licenses, technical information, privileges, rights, intellectual property, upgrades, or services that (1) may be necessary to access, exchange or use EHI and (2) are controlled by the actor. Such control includes the ability to confer all rights and authorizations necessary to use the element to enable the access, exchange or use of EHI.”

    Upon receiving a request to license an interoperability element for the access, exchange or use of EHI, the actor must begin license negotiations with the requestor within 10 business days from receipt of the request and negotiate a license with the requestor, subject to the licensing conditions below (and other requirements of the Licensing Exception), within 30 business days from receipt of the request. The license for the interoperability element must meet the following conditions:

    • Scope of Rights. The license must provide all rights necessary to: enable the access, exchange or use of EHI and to achieve the intended access, exchange or use of EHI via the interoperability element.
    • Reasonable Royalty. If the actor charges a royalty for the use of the interoperability element, the royalty must be reasonable and comply with the following requirements:
      • The royalty must be non-discriminatory, consistent with the non-discriminatory terms requirement below.
      • The royalty must be based solely on the independent value of the actor’s technology to the licensee’s products, not on any strategic value stemming from the actor’s control over essential means of accessing, exchanging or using EHI.
      • If the actor has licensed the interoperability element through a standards developing organization in accordance with its policies regarding the licensing of standards-essential technologies on terms consistent with the licensing exception, the actor may charge a royalty that is consistent with such policies.
      • An actor may not charge a royalty for intellectual property if the actor recovered any development costs pursuant to the Fees Exception that led to the creation of the intellectual property.

    In the final rule preamble, ONC notes that whether a royalty is reasonable for purposes of the Licensing Exception requirement depends on the particular facts and circumstances. ONC also identifies the following non-exclusive list of potential factors for evaluating reasonableness:

    • The royalties received by the actor for the licensing of proprietary elements in other circumstances comparable to reasonable and non-discriminatory licensing circumstances.
    • The rates paid by the licensee for the use of other comparable proprietary elements.
    • The nature and scope of the license.
    • The effect of the proprietary elements in promoting sales of other products of the licensee and the licensor, taking into account only the contribution of the elements themselves and not of the enhanced interoperability that they enable.
    • The utility and advantages of the actor’s interoperability element over the existing technology, if any, that had been used to achieve a similar level of access, exchange or use of EHI.
    • The elements’ contribution to the technical capabilities of the licensee’s products, taking into account only the value of the elements themselves and not the enhanced interoperability that they enable
    • The portion of the profit or selling price that may be customary in the particular business or in comparable businesses to allow for the use of the proprietary elements or analogous elements that are also covered by reasonable and non-discriminatory terms commitments.
    • The portion of the realizable profit that should be credited to the proprietary elements as distinguished from non-proprietary elements; the manufacturing process; business risks; significant features or improvements added by the licensee; or the strategic value resulting from the network effects, switching costs, or other effects of the adoption of the actor’s technology.
    • The opinion testimony of qualified experts.
    • The amount that a licensor and a licensee would have agreed upon (at the time the licensee began using the elements) if both were considering the reasonable and non-discriminatory terms obligation under the Licensing Exception and its purposes, and had been reasonably and voluntarily trying to reach an agreement.
    • Non-Discriminatory Terms. The royalty and other terms on which the actor licenses and otherwise provides the interoperability element must be non-discriminatory and comply with the following requirements:
      • The terms must be based on objective and verifiable criteria that are uniformly applied for all similarly situated classes of persons and requests.
      • The terms must not be based in any part on:
        • Whether the requestor or other person is a competitor or potential competitor, or will be using EHI obtained via the interoperability elements in a way that facilitates competition with the actor; or
        • The revenue or other value the requestor may derive from access, exchange or use of EHI obtained via the interoperability elements.

    Accordingly, the royalty or other compensation terms in the license agreement for the interoperability element may not be a revenue share based on the revenue that the licensee generates from EHI transferred through the interoperability element.

    How does the condition of certification for APIs affect license fees and other charges?

    ONC finalized a condition of certification for certified APIs that includes, among other requirements, restrictions on the pricing practices of certified API developers. The requirements directly applicable to the fee restrictions are as follows:

    • Permitted Fees Generally. The condition of certification permits certified API developers to charge three categories of permitted fees and expressly allows the permitted fees to include a reasonable profit margin otherwise in accordance with the Fees Exception. All other fees related to certified API technology are prohibited. A certified API developer must ensure that:
      • All permitted fees are based on objective and verifiable criteria that are uniformly applied to all similarly situated hospitals, physician practices and other organizations that deploy certified API technology (API information sources), and persons or entities that create or use software applications that interact with the certified API technology (API users).
      • Permitted fees imposed on API information sources are reasonably related to the certified API developer’s costs to supply certified API technology to, and if applicable, support certified API technology for, API information sources.
      • Permitted fees to supply and support certified API technology are reasonably allocated among all similarly situated API information sources.
      • Fees are not based on whether API information sources or API users are competitors or potential competitors, or will use the API in a way that facilitates competition with the certified API developer.
    • Three Categories of Permitted Fees. The condition of certification permits the following categories of fees for certified API technology:
      • Permitted Fee: Development, Deployment and Upgrades. A certified API developer may charge fees to an API information source to recover the costs reasonably incurred by the certified API developer to develop, deploy and upgrade certified API technology.
      • Permitted Fee: Recovering API Usage Costs. A certified API developer may charge fees to an API information source related to the use of certified API technology, provided that the fees are limited to the recovery of incremental costs reasonably incurred by the certified API developer when it hosts certified API technology for the health care provider or other API information source.
      • Permitted Fee: Value-Added Services. A certified API developer may charge fees to an API user for value-added services related to certified API technology, as long as the services are not necessary to efficiently and effectively develop and deploy production-ready software that interacts with the certified API technology.
    • Prohibited Fees. Consistent with the Fees Exception, the condition of certification prohibits a certified API developer from charging a fee for:
      • Costs associated with intangible assets other than actual development or acquisition costs of such assets;
      • Opportunity costs unrelated to the access, exchange or use of EHI; and
      • Any costs that led to the creation of intellectual property if the actor charged a royalty for that intellectual property pursuant to the Licensing Exception and the royalty included the development costs for the creation of the intellectual property.
    • Non-Discrimination. A certified API developer must meet the following non-discrimination requirements when setting fees and other terms with respect to certified API technology:
      • Provide the certified API technology to an API information source on terms that are no less favorable than the certified API developer provides to itself and its own customers, suppliers, partners and other persons with whom it has a business relationship;
      • Base the terms for the provision of certified API technology on objective and verifiable criteria that are uniformly applied to all substantially similar or similarly situated classes of persons and requests;
      • Not offer different terms or services based on whether a competitive relationship exists or would be created; and
      • Not offer different terms or services based on the revenue or other value that another party may receive from using the API technology.
    • Description of API Fees. The certified API developer must describe all fees that it charges for the use of its certified API technology in detailed, plain language. The description must include all material information, including the persons or classes of persons to whom the fee applies; the circumstances in which the fee applies; and the amount of the fee, which for variable fees must include the specific variables and methodologies used to calculate the fee.
    • Record-Keeping Requirements. A certified API developer must keep detailed records of any fees charged with respect to the certified API technology, the methodologies used to calculate the fees and the specific costs to which such fees are attributed. In the final rule preamble, the ONC states it expects that “the accounting practices already used by health IT developers will largely support the health IT developer to meet this requirement. Examples of these practices by health IT developers include the methods used to track their own investments, determine how to bill and issue invoices to their customers, document receipt of payment, and to maintain overall accurate financial records of business transactions.”

    What is the analytical framework for determining whether charges for health IT comply with an information blocking exception under the final rule and, if applicable, the condition of certification for APIs?

    If an entity desires to impose a fee or other charge for an interoperability element or EHI access, exchange or use, to the extent the information blocking prohibition applies, the entity must design the fee to meet an exception to the information blocking prohibition and any applicable conditions of certification for certified health IT, such as the restrictions on fees for certified APIs. Accordingly, the entity should consider the following questions:

    • Covered Actor. Is the entity seeking to charge the license fees or other charges for use of APIs and other technology to access, exchange or use EHI an actor subject to the final rule (i.e., a health care provider, certified health IT developer, or an HIN or HIE)?
    • EHI. Does the proposed fee or other charge relate to EHI, as opposed to HIPAA de-identified health information or other information outside the definition of EHI, such as (for the 24 months after the publication of the final rule in the Federal Register), information that is not included in the USCDI data set?
    • Interoperability Element or Access, Exchange or Use. Is the proposed fee or other charge for (1) a license or other right to use an interoperability element or (2) providing access, exchange or use of EHI? For example, is the fee in exchange for a license for an API that enables access to EHI stored in an EHR system? Is the fee for a license to elements of EHR software or other health IT that only stores EHI rather than providing access, exchange or use of EHI? Alternatively, is the fee for participation in an HIN or HIE?
    • Information Blocking Exception. Does the proposed fee or other charge meet the Content and Manner Exception, Fees Exception or Licensing Exception? The Content and Manner Exception provides the greatest flexibility for actors relative to pricing and terms and may, therefore, be the most advantageous exception for actors to consider first. Between the Licensing Exception and the Fees Exception, the Licensing Exception is typically more attractive if the applicable costs are low, so it may be advantageous to consider that exception before the Fees Exception.
    • Additional Requirements for Certified API Technology. If the proposed fee or other charge relates to a certified API, does the proposed pricing practice meet the additional requirements of the condition of certification for APIs?

    What are the key next steps for a certified health IT developer to ensure fees and other charges comply with the final rule’s information blocking prohibition and condition of certification for certified APIs?

    A certified health IT developer should consider at least the following key steps to implement compliance.

    • Step 1: Identify all executed and template contracts and other arrangements under which the developer provides technology that includes any capability or service that enables access, exchange or use of EHI to third parties rather than merely storing EHI.
    • Step 2: Develop a business strategy and process for amending non-compliant arrangements with current customers and other counter-parties within the six-month period before the final rule’s compliance date for its information blocking provisions and for negotiating market terms with prospective counter-parties under the arrangements identified in Step 1 in accordance with the Content and Manner Exception.
    • Step 3: Revise any template pricing terms that do not meet the restrictions of the Fees Exception or Licensing Exception in order to be prepared for the failure of negotiations of market terms in accordance with the Content and Manner Exception.
    • Step 4: Develop a business process for responding to third-party requests to license an interoperability element, including its deadlines for beginning license negotiations and completing negotiations of a license agreement.
    • Step 5: Ensure that any template license or other agreement with a new customer for an EHR system specifies any fees to export or convert data from the EHR system in order to avoid the prohibition on export and conversion fees that are not agreed to in writing at the time the EHR system is acquired.
    • Step 6: Determine how to reasonably allocate certified API supply and support costs among similarly situated API information sources, including determining reasonably likely costs and forecasting the number of API information sources deploying the certified API.
    • Step 7: Determine whether existing accounting practices maintain detailed records of fees charged with respect to the certified API and other technology, the methodologies used to calculate the fees and the specific costs to which such fees are attributed. If existing practices do not maintain detailed records of these items, establish a practical business process to attribute fees to costs and a record keeping system to track required information.

    What are the key next steps for a health care provider (that is not a certified health IT developer) to ensure that its contracts and other arrangements comply with the fee restrictions in the final rule’s exceptions to the information blocking prohibition?

    A hospital, physician practice or other health care provider actor should consider the following steps to implement compliance with the information blocking prohibition:

    • Step 1: Identify all contracts and other arrangements under which the health care provider licenses or otherwise obtains an interoperability element or service from a certified health IT developer or other actor that enables access, exchange or use of EHI rather than merely storing EHI.
    • Step 2: Evaluate the arrangements identified under Step 1 to determine whether any fees may fail to meet the limitations imposed under the applicable final rule exception, and if so, consider requesting modified pricing terms for non-compliant arrangements.
    • Step 3: Develop a business strategy and process for responding to requests from physician practices and other health care provider requestors that have common patients with the health care provider receiving the request, for access, exchange or use of EHI maintained by the receiving health care provider. For example, a community physician practice may request that a hospital with common patients establish a custom interface to enable seamless access to EHI about common patients maintained by the hospital.

    Summary Chart*

    Our summary chart, available here, identifies all of the restrictions directly applicable to fees charged by an actor under the final rule. The first column of the chart identifies a restriction affecting fees. The second column indicates whether the fee restriction in the first column is an element of the Licensing Exception. The third column indicates whether the restriction in the first column is an element of the Fees Exception. The fourth column indicates whether the restriction applies to developers of certified APIs.

    *For more information about elements of the exceptions that are not directly related to fees charged by an actor, please see McDermott’s prior Special Report comprehensively covering the information blocking provisions of the final rule.

    Please do not hesitate to contact your regular McDermott lawyer or any one of the authors of this On the Subject if you have questions or need assistance with understanding the fee restrictions under the final rule.

    For an in-depth discussion of the final rules and their impact on your organization, view the recordings of our March 2020 webinar series.

    Authors

    Daniel F. Gottlieb

    Partner

    Chicago

    James A. Cannatti III

    Partner

    Washington, DC

    More insights

  • Force Majeure and COVID-19: Frequently Asked Questions

    Force Majeure and COVID-19: Frequently Asked Questions

    ARTICLE / CLIENT ALERT

    Force Majeure and COVID-19: Frequently Asked Questions

    March 20, 2020

    Read time: 12 min

    Key takeaways
    Overview

    In light of the novel Coronavirus (COVID-19) pandemic, many businesses are confronting circumstances that may excuse or delay their obligations to perform under existing contracts due to the occurrence of a force majeure event. This FAQ addresses common questions about force majeure and when and how COVID-19 might trigger such provisions.

    In depth

    In light of the novel Coronavirus (COVID-19) pandemic, many businesses are confronting (for the first time in their corporate history) circumstances that may excuse or delay their obligations to perform under existing contracts due to the occurrence of a force majeure event.

    Force majeure is a contractual defense that allows a party to suspend or discontinue performance of its contractual obligations under specific circumstances. It may also operate to limit a contract party’s liability. What constitutes a force majeure event is determined on a case-by-case basis and depends upon the terms of the relevant contract, applicable law and other relevant facts.

    Many force majeure provisions include a list of specific events that are not “reasonably foreseeable” and that are also beyond the parties’ control. A global pandemic such as COVID-19 (or its downstream effects and consequences) will likely qualify as a force majeure event if the provision specifically includes references to a “pandemic,” “epidemic” and/or “disease.” If the pertinent force majeure provision does not contain such specific disease references, other more generic “catch-all” provisions pertaining to “disasters,” “acts of God,” “national emergencies,” “government regulations” or “acts beyond the control of the parties” may be asserted to allege that COVID-19 and its downstream effects or consequences are indeed force majeure events.

    1. How does COVID-19 affect contractual obligations?

    • COVID-19 was first detected in Wuhan, China, in December 2019. Only a few months later, COVID-19 was declared by both the World Health Organization and Center for Disease Control a global pandemic that raised “a public health emergency of international concern.”
    • Governments and businesses have implemented measures to prevent or curtail the spread of the virus in the form of travel bans, heightened border security (and in some cases border closures), restrictions on gathering sizes, closure of non-essential stores and businesses, cancelation of public events (including concerts and sporting events), and other similar measures.
    • Consequently, many businesses are simply unable to perform their contractual obligations. Some have invoked force majeure to eliminate or limit liability due to their inability to perform such contractual obligations. Similarly, some companies have cancelled various contracts for goods and services in light of travel restrictions and other limitations.

    2. What is force majeure?

    • In general terms, force majeure refers to a contractual provision that limits liability due to unforeseen events outside the control of the parties that delay performance of the contract or prevent performance entirely.
    • In the United States, all contract law matters are governed by state law. Therefore, the ability to claim force majeure depends upon the existence of an express force majeure provision in the contract, and the scope of relief offered under applicable state law. In general, courts will enforce a force majeure provision according to its terms.
    • A party’s ability to delay or discontinue performance based upon a force majeure event depends upon the specific terms of the contract analyzed in conjunction with applicable facts and law.
    • Where only one of the contract parties asserts a force majeure defense, the allegation may relieve the other counterparty from performance of its obligations as well, but this will depend on the nature of the obligations and the applicable law.

    3. What type of events qualify as force majeure?

    • Each force majeure provision must be considered on its own precise terms. Some general features common to most force majeure provisions include:
      • The event was outside the reasonable control of a party;
      • The event was not reasonably foreseeable by the parties, and the effects therefore could not be avoided;
      • The relevant event materially affects the ability of one or more of the parties to perform their contractual obligations; and
      • The party or parties took all reasonable steps to try to provide notice and to avoid or mitigate the relevant event or its consequences.
    • Typically, a force majeure provision becomes applicable when performance becomes impossible and not when it simply becomes burdensome.
    • In general, a force majeure provision excuses performance based upon the occurrence of specific qualifying events that constitute force majeure or that fall within the purview of a broader “catch-all” category of events that may qualify as force majeure events. These may include “acts of God,” war, fire, national emergencies, labor strikes, diseases, pandemics, epidemics, natural disasters, governmental acts or regulations, and other “acts beyond the control” of the parties.
    • Other remedies that may be articulated in the contract or may be available under applicable law include extensions of time for completion or performance, the ability to terminate or suspend performance (in full or in part), and/or avoidance of liability.
    • The contract may also state that the party affected by force majeure must first comply with certain obligations in order to take advantage of the protections offered by the provision.
      • For example, the provision might require the affected party to provide notice to the counterparty and continue efforts to recommence performance to the extent possible, including through the use of alternate sources and workaround plans.
    • In many instances, exercising a party’s disaster recovery and business continuity obligations and payment of fees is excluded from the force majeure provision.
    • Domestic and international laws in both common law and civil law jurisdictions differ vastly with respect to how broadly or narrowly force majeure provisions are interpreted.

    4. How does a party prove that an event was not “reasonably foreseeable” and therefore was outside its control?

    • This is highly fact-specific. Most contracts contain specific lists of force majeure events that qualify as occurrences that are not “reasonably foreseeable” and are beyond a party’s control.
    • If a party wishes to have an event such as the COVID-19 outbreak considered as a force majeure event, it would be ideal for the relevant provision to specifically include “pandemics,” “epidemics” or “disease.” Given the fact-specific analysis, each case must be evaluated individually.
    • Even if the relevant force majeure provision does not contain such specific references, “catch-all” provisions such as “national emergencies,” “acts of God,” “governmental actions or regulations,” or “acts beyond the control” of the parties may also qualify COVID-19 and its downstream effects or consequences as a force majeure event.

    5. What quantifiable impact is sufficient to demonstrate that COVID-19 had a “material impact”?

    • The degree of impact or impairment of a party’s performance on its contractual obligations will depend on the facts and circumstances of each situation.
    • A contract party asserting force majeure must establish a causal link between the relevant event and the party’s inability to perform. For example, the current and evolving restrictions designed to prevent the spread of COVID-19 may make it impossible to timely perform under the contract.
    • The contract will dictate the circumstances under which performance will be excused (e.g., if a party’s performance is “impeded,” “hindered,” “prevented” or “interfered with”).
    • A disruption that affects only the contract’s profitability may not be sufficient to constitute a force majeure event unless there is express language addressing profitability.
    • An economic downturn or generally adverse business conditions are probably insufficient to constitute a force majeure event, even if it can be proven that such downturn was specifically caused by COVID-19.

    6. What constitutes sufficient notice?

    • Force majeure provisions generally require that the party asserting excuse of performance notify the counterparty of the relevant force majeure event(s) and provide required support. Some contracts contain detailed procedures and timelines for such notice. Some states require strict compliance with the notice provision in the contract when providing notice of force majeure.
    • If the force majeure provision is silent concerning notice, the noticing party nevertheless may want to provide preliminary notice of the possibility of force majeure once it becomes evident that performance may be delayed or rendered impossible. The notice can always be amended or supplemented as additional details become available.
    • Parties should always take care before asserting force majeure to avoid a premature claim for breach of contract or anticipatory repudiation. The counterparty may also seek to terminate the contract or avoid its own performance after receiving a notice of a force majeure event. If a legitimate force majeure defense is asserted, the party asserting force majeure will not be liable for breach of contract.

    7. How does a party prove that it attempted to mitigate or avoid the force majeure event?

    • If an event qualifies as force majeure and proper notice was given to the counterparty, a party relying on force majeure may still be found liable for not mitigating the harm derived from the non-performance of its obligations. The extent of the mitigation requirement is fact-specific and will depend on the language of the provision as well as applicable law and the facts.
    • Where an alternative to non-performance is available, the contract parties should consider such alternatives in light of the relevant burdens and costs.

    8. Can a party still be sued if a qualifying event occurs, proper notice is given and mitigation occurs?

    • Given that the determination of a qualifying event, proper notice and mitigation are all subject to interpretation, litigation may ensue if the parties do not agree on these elements.
    • It is important to analyze and consider the dispute resolution mechanism articulated in the contract or available under applicable law.

    9. Are there differences between common and civil law jurisdictions regarding force majeure?

    • There are important differences between the treatment of force majeure under common law and civil law jurisdictions.
    • In common law jurisdictions (such as the United States and the United Kingdom), force majeure is not implied in contracts. Contract parties therefore must include such provisions expressly in the contract. Consequently, force majeure provisions can be negotiated to include broad or narrow terms.
    • In civil law jurisdictions, force majeure generally is implied in contracts, so specific provisions are less frequently included in contracts. However, where they are included, they may allow the parties to circumvent possible limitations on the doctrine set forth in the applicable law.
    • Even if the contract or applicable law does not provide a force majeure defense, some jurisdictions, including some US states, allow a contract party to assert analogous defenses under common law, such as “impossibility,” “impracticability” or “frustration of purpose.”

    10. Will consequences arising from COVID-19 constitute force majeure?

    • The extent to which COVID-19 and its downstream effects and consequences constitute a qualifying force majeure event is highly fact-specific and depends on the terms of the contract, the specific facts, governing law and how courts in the relevant jurisdiction(s) interpret force majeure provisions, among other things.
    • Even if a contract does not have a specific force majeure provision, applicable law may allow a party to excuse performance under other theories in the face of unexpected events.
    • The law is likely to evolve as a result of COVID-19, and many court rulings may result from this pandemic.

    11. What steps can I take if force majeure might apply to my contract?

    • Review your contract to determine whether the contract includes a force majeure provision, including:
      • The specific events and circumstances that qualify for force majeure treatment
      • Other relevant terms and conditions in the contract (including governing law, events of default, dispute resolution, etc.)
    • Analyze whether the performance of any of the parties under the contract will be impracticable or impossible because of the direct or indirect consequences of COVID-19 and not for a different reason.
    • Take all steps necessary to mitigate or reduce the effects of COVID-19 (including its downstream effects and consequences) on your ability to perform under the relevant contract.
    • Timely comply with any notice requirements, including the production of documentary support and the specific method of notice (e.g., by registered or overnight mail to a specific address).
    • Consider the potential consequences or downstream impacts of the counterparty suspending its performance under the contract if you notify it of a force majeure event.
    • Determine whether potential insurance coverage is available, including business interruption insurance or an event-specific insurance policy.
    • Document all steps taken to mitigate or avoid the impact of COVID-19 (or its downstream effects and consequences) on your ability to perform under the contract, as well as all other relevant facts and circumstances and the steps you have taken to provide notice.

    12. What should I do if I receive a force majeure notice?

    • Carefully examine the notice to determine:
      • Whether it falls within the scope of the force majeure provision or applicable law
      • Whether the form and timing of the notice was proper
      • The availability and impact of applicable laws and facts
      • When and how to respond, whether your performance or payment is excused, and whether to terminate the contract in response to the notice.
    • Consider whether the notice has a downstream impact on any other contracts, and consider whether you should provide a copy of the notice to other parties.
    • Consider if the party claiming force majeure has fulfilled its other obligations under the contract. For example, did the party have an obligation to implement a business continuity plan or otherwise try to find a work-around to the situation?
    • Remember that in most states, an injured party has an obligation to mitigate its damages even if the force majeure claim is not proper and the non-performing party is in breach of contract.

    13. What if a contract does not have a force majeure clause or the force majeure clause does not address the specific circumstance in question?

    • There is a common law doctrine that if it is impossible to perform the contract due to circumstances that could not be reasonably anticipated, then failure to perform the contract is excused or delayed. The exact parameters of that doctrine vary by jurisdiction and will depend upon which jurisdiction’s law governs the contract.
    • The law in some jurisdictions might also provide that performance of a contract can be excused or delayed if there are unexpected circumstances that make performance of the contract impracticable or that frustrate performance, thereby depriving a party of the benefit of the contract.
    Authors

    Lisa M. Richman

    Partner

    Washington, DC

    Shawn C. Helms

    Partner

    Dallas

    Jason D. Krieser

    Partner

    Dallas

    Paul M. Thompson

    Partner

    Washington, DC

    More insights

  • Broker-Dealers: B-D Guidance on Increased Cybersecurity Risks Due to the COVID-19 Pandemic

    Broker-Dealers: B-D Guidance on Increased Cybersecurity Risks Due to the COVID-19 Pandemic

    ARTICLE / CLIENT ALERT

    Broker-Dealers: B-D Guidance on Increased Cybersecurity Risks Due to the COVID-19 Pandemic

    March 20, 2020

    Read time: 11 min

    Key takeaways
    Overview

    As most broker-dealers move to a telework model and navigate the “new normal,” it is critical that they take steps to mitigate the increased cybersecurity risks arising from the COVID-19 pandemic.

    Guidance on Increased Cybersecurity Threats

    On March 9, 2020, FINRA issued Regulatory Notice 20-08, advising members to review their business continuity plans and prepare themselves for heightened cybersecurity risks as they face significant business disruptions in the wake of the COVID-19 pandemic. FINRA reminds members that the pandemic has increased cybersecurity risks due to a combination of increased remote work and heightened anxiety and confusion about the virus among employees. The Regulatory Notice contains a number of steps that FINRA also recommends member firms take to mitigate those increased risks and vulnerabilities.

    On March 13, 2020, the U.S. Department of Homeland Security’s Cybersecurity and Infrastructure Security Agency (“CISA”) issued a similar alert that, although not specific to broker-dealers, provides additional information for organizations moving to a remote working environment and the steps they should take to adopt a heightened state of cybersecurity. In particular, CISA warns firms to anticipate sophisticated phishing attacks and to help employees to be on alert for these attacks.

    Suggested cyber mitigation efforts include:

    • Ensuring that virtual private networks (“VPNs”) and other remote access systems are properly patched with the latest available security updates and configurations;
    • Checking that system entitlements are current;
    • Employing the use of multifactor authentication (“MFA”) for associated persons who access systems remotely and implementing MFA on all VPN connections to increase security;
    • Reminding associated persons of cyber risks through education and other exercises that promote heightened vigilance;
    • Ensuring IT security personnel are prepared to ramp up remote access cybersecurity tasks, including log review, attack detection, and incident response and recovery and document these tasks in the configuration management policy; and
    • Ensuring IT security personnel test VPN limitations to prepare for mass usage and, if possible, implement modifications — such as rate limiting — to prioritize users that will require higher bandwidths.

    Cyber SARs

    As a reminder, broker-dealers and other financial institutions are required to file Suspicious Activity Reports (“SARs”) with the U.S. Department of the Treasury’s Financial Crimes Enforcement Network for certain cyber-events and cyber-enabled crime.[1] Filing a SAR does not relieve financial institutions of any other applicable notification requirements, and compliance with the Cybersecurity Information Sharing Act does not relieve financial institutions of any SAR reporting requirements  for cyber-events or cyber-enabled crime.

    The Biggest Cybersecurity Weakness May Be Your Employees

    Both FINRA and CISA guidance emphasize the need for employees to practice heightened vigilance with respect to cybersecurity risks that will exploit human beings as a weak link. CISA and other government agencies have been warning for several weeks about the risks posed by cyber criminals and other scammers exploiting the pandemic.[2] 

    In particular, broker-dealers must regularly remind employees of the dangers posed by phishing emails. Phishing emails are becoming more sophisticated and difficult to spot, and are being designed to exploit uncertainty and anxiety about the pandemic. Reported phishing attempts already reported during this crisis include:

    • Communications that look like they were sent by the World Health Organization[3] or another health or governmental organization;
    • Fake purchase orders for face masks or other supplies;
    • False “remote workplace testing” emails that request login or other authentication information; and
    • Requests for donations that spoof legitimate relief organizations.

    To succeed, a phishing attack only needs to convince one employee to click a link, open an attachment, or provide authentication information, which could compromise the firm’s security or unleash malware that could render some or all firm systems inaccessible for an extended period of time. Under the best of circumstances, a successful phishing attack can cause significant harm and business interruptions. Where firms have moved partially or fully to remote work, or where on-site IT monitoring and support has been reduced, they can be even more debilitating and difficult to address.

    Because employees are a major point of vulnerability, email alerts, trainings (which can be conducted via webinar or teleconference), and phishing tests (i.e., sending phishing simulation emails) can go a long way in mitigating the risks. Existing information security training programs and materials can and should be leveraged for this purpose, and tailored to the extent possible to current COVID-19 situation.

    Have a Plan for Responding to a Cybersecurity Incident

    Finally, firms should prepare for the potential eventuality of a cybersecurity incident. Firms should evaluate any team and response plan currently in place to ensure that it is capable of responding in the current environment. Should a cybersecurity incident occur, firms must consider whether any notices are required to personnel, other affected individuals (e.g., customers or clients) or, governmental authorities. For example, if client information is accessed or extracted from a firm’s systems, it could trigger reporting obligations under various data breach notifications laws.

    Authored by Craig S. Warkol, Edward H. Sadtler, Derek N. Lacarrubba, Kelly Koscuiszka, David S. Sieradzki, Katherine M. Sullivan and Amanda C. Wichot.

    If you have any questions concerning this Alert, please contact your attorney at Schulte Roth & Zabel or one of the authors.


    [1] See FIN-2016-A005, issued Oct. 25, 2016.

    [2] For example, CISA issued a March 6 alert regarding cyber scams related to the coronavirus; the Federal Trade Commission issued a Feb. 10 alert related to fake websites, emails, and fundraising efforts related to the coronavirus, and the Securities and Exchange Commission’s Office of Investor Education and Advocacy issued a Feb. 4 investor alert warning investors about investment frauds involving claims that a company’s products or services will be used to help stop the coronavirus outbreak.

    [3] The World Health Organization maintains a cybersecurity page with tips to assist organizations in validating communications and a link for reporting scams.


    This communication is issued by Schulte Roth & Zabel LLP for informational purposes only and does not constitute legal advice or establish an attorney-client relationship. In some jurisdictions, this publication may be considered attorney advertising. ©2020 Schulte Roth & Zabel LLP.

    All rights reserved. SCHULTE ROTH & ZABEL is the registered trademark of Schulte Roth & Zabel LLP.

    In depth
    Authors

    Kelly Koscuiszka

    Partner

    New York – 919 Third Avenue

    More insights

  • FDIC Approves Deposit Insurance for Two Industrial Bank Applicants and Proposes New Rules for Future Applicants

    FDIC Approves Deposit Insurance for Two Industrial Bank Applicants and Proposes New Rules for Future Applicants

    ARTICLE / CLIENT ALERT

    FDIC Approves Deposit Insurance for Two Industrial Bank Applicants and Proposes New Rules for Future Applicants

    March 20, 2020

    Read time: 7 min

    Key takeaways
    Overview

    On March 18, 2020, the Federal Deposit Insurance Corporation (“FDIC”) announced it had approved deposit insurance applications for two industrial bank applicants — Square Inc. and Nelnet Inc. Those decisions represented the first time since 2008 that the FDIC had been willing to grant deposit insurance to an industrial bank applicant. Since deposit insurance is a prerequisite for obtaining an industrial bank charter, the FDIC’s moratorium — sometimes official, sometimes unofficial — had put the charter on ice for more than a decade.[1]

    On March 17, 2020, the FDIC also issued for public comment a proposed rule that would impose certain conditions on industrial bank applicants going forward. These developments, which are discussed further below, indicate that the FDIC has changed its position with regard to approving deposit insurance applications for industrial bank applicants, and the once highly sought after industrial bank charter may begin to garner serious attention once again.

    What Is the Value of the Industrial Bank Charter?

    Under U.S. banking law, generally, an entity that is deemed to control a banking organization is subject to regulation by the Board of Governors of the Federal Reserve System (“Board”) as a bank holding company or a savings and loan holding company. Such regulation is extensive and pervasive, including capital requirements, liquidity requirements, leverage limitations, “source of strength” obligations and activity restrictions.

    However, there are exceptions to this general rule for entities that control “limited purpose banks,” such as industrial banks and special purpose national banks chartered by the Office of the Comptroller of the Currency (“OCC”) (which currently exist in two forms — trust banks and credit card banks).[2] While both existing types of special purpose national banks have very limited powers (as their names would indicate, a trust bank is largely limited to conducting fiduciary activities and a credit card bank is generally limited to consumer credit card lending), an industrial bank, in contrast, can engage in virtually all activities that a regular bank can engage in and, as such, was and is now again a potentially attractive bank charter.

    What Are Industrial Banks?

    Industrial banks (also sometimes referred to as “industrial loan companies”) have existed in the United States since 1910, originally created to provide loans to low and moderate-income industrial workers who had stable jobs but little access to bank credit. In the early years of the industry, a majority of the states offered some form of industrial bank charter. During the past decade, however, this number dropped to just seven states, and currently only six states still have active FDIC-insured industrial banks. Of those six, however, only Utah and Nevada offer charters that are able to fully benefit from the federal law treatment discussed above, which was enacted by Congress in 1987.[3]

    Because the owners of industrial banks are not subject to most of the requirements imposed on bank holding companies and savings and loan holding companies, they may be owned by entities that would not be eligible to own a commercial bank or savings and loan association. In 1988, General Motors was the first such company to charter an industrial bank. Following General Motors, numerous other commercial companies, including manufacturers and retailers, obtained a charter.

    Recently, the industrial bank charter has received a lot of attention from fintech companies, which may now consider revisiting such a charter as an option going forward.

    As noted above, while the owners of OCC-chartered trust banks and credit card banks (and, perhaps in the future, fintech banks) receive the same federal law benefit as the owners of industrial banks, such charters are far more limited and, thus, less attractive to most potential applicants. In contrast to other limited purpose charters, the only significant limitation on the powers of an industrial bank is that it cannot offer “demand deposits” (such as traditional checking accounts) if the bank’s total assets exceed $100 million. However, industrial banks may offer negotiable order of withdrawal (“NOW”) accounts, which function much like a traditional checking account, with the only difference being that the bank has the right to require at least seven days’ written notice of a withdrawal, though for competitive reasons banks nearly always automatically waive such right. Thus, in practice, an industrial bank can be virtually indistinguishable from a full-service bank. Moreover, like a full-service bank, an industrial bank enjoys federal preemption of interest rate limitations, allowing the industrial bank to export to out-of-state borrowers the interest rate permitted by the state in which it is located.

    What Conditions Will the FDIC Impose on Industrial Bank Applicants?

    In approving the Square and Nelnet applications, the FDIC required each to enter into a Capital and Liquidity Maintenance Agreement and a Parent Company Agreement. Through the former, the FDIC required each applicant to agree to (i) serve as a source of financial strength for its bank; (ii) ensure that the bank maintains sufficient capital and liquidity; and (iii) inject capital or liquidity if the bank’s capital or liquidity falls below a certain threshold. The latter agreement requires each applicant to consent to examination, reporting, recordkeeping and other provisions designed to provide safeguards to protect its bank and the Deposit Insurance Fund.

    As noted above, the day before announcing its approval of the applications, the FDIC issued a proposed rule that would require certain conditions and commitments for each deposit insurance application approval, non-objection to a change in control notice, and merger application approval that would result in an insured industrial bank becoming, after the effective date of any final rule, a subsidiary of a company that is not subject to consolidated supervision by the Board. The proposed rule would require a covered parent company to enter into written agreements with the FDIC and the industrial bank to (i) address the company’s relationship with the industrial bank; (ii) require capital and liquidity support from the parent to the industrial bank; and (iii) establish appropriate recordkeeping and reporting requirements. Comments on the proposed rule are due 60 days from its publication in the Federal Register. We plan to issue an upcoming Alert with more details on the proposal.

    Authored by Donald J. Mosher, Joseph P. Vitale and Adam J. Barazani.

    If you have any questions concerning this Alert, please contact your attorney at Schulte Roth & Zabel or one of the authors.


    [1] In 2006, the FDIC declared a self-imposed moratorium of the approval of applications for FDIC deposit insurance made by industrial banks, which expired in 2008. An additional moratorium was imposed by the Dodd-Frank Act in 2010, which expired in 2013. Since then, the FDIC has “slow-walked” applications, causing applicants to withdraw.

    [2] While the OCC created a third type of special purpose national bank in 2018, a financial technology (“fintech”) bank, such a charter has never been issued, as the OCC’s authority to do so has been the subject of litigation. In October 2019, the district court for the Southern District of New York entered a final judgment in favor of the New York Department of Financial Services, who had filed a lawsuit challenging the OCC’s authority to offer fintech bank charters. In December 2019, the OCC filed its appeal and the case is still pending.

    [3] In Nevada, industrial banks operate under a “limited purpose thrift company” charter.


    This communication is issued by Schulte Roth & Zabel LLP for informational purposes only and does not constitute legal advice or establish an attorney-client relationship. In some jurisdictions, this publication may be considered attorney advertising. ©2020 Schulte Roth & Zabel LLP.

    All rights reserved. SCHULTE ROTH & ZABEL is the registered trademark of Schulte Roth & Zabel LLP.

    In depth
    Authors

    Donald J. Mosher

    Partner

    New York – 919 Third Avenue

    Adam J. Barazani

    Partner

    New York – 919 Third Avenue

    More insights

  • Broker-Dealers: B-D Guidance on Business Continuity Planning During the COVID-19 Pandemic — Considerations for an Evolving Emergency

    Broker-Dealers: B-D Guidance on Business Continuity Planning During the COVID-19 Pandemic — Considerations for an Evolving Emergency

    ARTICLE / CLIENT ALERT

    Broker-Dealers: B-D Guidance on Business Continuity Planning During the COVID-19 Pandemic — Considerations for an Evolving Emergency

    March 20, 2020

    Read time: 6 min

    Key takeaways
    Overview

    On March 9, 2020, the Financial Industry Regulatory Authority (“FINRA”) issued Regulatory Notice 20-08 (“Regulatory Notice”) in response to the COVID-19 pandemic, providing guidance related to Rule 4370 Business Continuity Plans and Emergency Contact Information. In the wake of the COVID-19 pandemic, many FINRA member firms are now contemplating an extended period of time where business operations will involve significant numbers of employees working remotely. Members are advised in the Regulatory Notice to review the sufficiency of their business continuity plans (“BCPs”) and emergency procedures to deal with this reality. As the COVID-19 situation evolves, firms must have supervisory procedures that are, or can be, adapted to a remote work environment, including clear directives for how to escalate compliance issues. Furthermore, firms must, as the Regulatory Notice states, be aware of the increased cybersecurity risks inherent in telework, and respond to those risks in a reasonable way.

    Business Continuity Plans and Emergency Contact Information

    • Rule 4370 (Business Continuity Plans and Emergency Contact Information) requires members to create, maintain, review at least annually and update upon any material change, a BCP identifying procedures relating to an emergency or significant business disruption.[1] In the days since FINRA issued the Regulatory Notice, the governmental response to the COVID-19 pandemic has evolved rapidly, and member firms are now facing an unprecedented and extended period of business disruption.
    • The Regulatory Notice urges member firms to review their BCPs with an eye to “pandemic preparedness.” Part of that preparedness is pre-testing remote office or telework arrangements prior to activating a BCP.
    • If firms have not yet activated their BCP, they should expend best efforts to test remote connectivity with critical firm systems, and to assess the adequacy of employees’ internet access and any VPNs, and to ensure that business can continue without significant interruption even in the event of large scale remote work.
    • Firms that have activated their BCPs should continue to evaluate whether they adequately mitigate the rapidly evolving business risks of the response to the COVID-19 pandemic, update their BCPs if necessary, and ensure that critical systems and remote connectivity solutions are working as expected as this national crisis continues to evolve.

    How Can Firms Be Pandemic Prepared?

    • In addition to addressing connectivity and other operational logistics involved in running a broker-dealer with large numbers of employees teleworking, FINRA member firms should ensure that their compliance systems can continue to function effectively. The Regulatory Notice advises members that they will be expected “to establish and maintain a supervisory system that is reasonably designed to supervise the activities of each associated person while working from an alternative or remote location during the pandemic.”
    • Member firms should review their written supervisory procedures to ensure that all compliance and control functions can continue to be seamlessly integrated with remote business functions.
    • For example, where supervisory oversight has historically relied, at least in part, upon proximity, such as with a supervisor sitting on a trading desk, the firm should ensure that it can digitally or electronically replicate that oversight.
    • Supervisory personnel should be included in group chats or video conferences regarding activities by associated persons that they would typically supervise in person.

    Emergency Contacts As Pandemic Preparedness

    • FINRA Rule 4370 mandates the appointment of emergency contact personnel, a requirement designed primarily to facilitate communication to and from the firm in the aftermath of a short term, acute, event-based emergency. The COVID-19 pandemic is an emergency of a different sort.
    • While the Regulatory Notice reminds firms of their obligation to designate two emergency contact persons with whom FINRA may communicate, firms should also consider the necessity of more robust procedures as employees face the possibility of prolonged remote working situations, extended quarantines, and significant medical complications.
    • Firms should create, document, and clearly communicate to employees contact information and escalation procedures to be used when questions arise in the course of doing business remotely, especially around legal and compliance issues and notification procedures in the event that a critical employee is unable to work. Employees should know who to call if the person they would typically ask a question is not available and firms should be in a position to rapidly update these contacts as the situation evolves.
    • Phone trees and organization charts providing secondary and tertiary resources to employees will help firms avoid remote work becoming a compliance ‘self-help’ scenario.

    Cybersecurity Considerations

    Remote work brings additional cybersecurity risks. The Regulatory Notice contains a number of steps that FINRA also recommends member firms take to mitigate those increased risks, including taking steps to ensure that remote access remains both available and maximally secure, as well as encouraging heightened vigilance in a dispersed workforce. For more information about cybersecurity guidance for broker-dealers in the wake of COVID-19, please see our SRZ Alert Broker-Dealers: B-D Guidance on Increased Cybersecurity Risks Due to the COVID-19 Pandemic (March 20, 2020), available here.

    Authored by Craig S. Warkol, Derek N. Lacarrubba, David S. Sieradzki, Katherine M. Sullivan and William J. Barbera.

    If you have any questions concerning this Alert, please contact your attorney at Schulte Roth & Zabel or one of the authors.


    [1] FINRA Rule 4370 Business Continuity Plans and Emergency Contact Information is available here.


    This communication is issued by Schulte Roth & Zabel LLP for informational purposes only and does not constitute legal advice or establish an attorney-client relationship. In some jurisdictions, this publication may be considered attorney advertising. ©2020 Schulte Roth & Zabel LLP.

    All rights reserved. SCHULTE ROTH & ZABEL is the registered trademark of Schulte Roth & Zabel LLP.

    In depth
    Authors

    William J. Barbera

    Partner

    New York – 919 Third Avenue

    More insights

  • Commercial Leasing — Financial Issues Facing Landlords and Tenants Related to COVID-19

    Commercial Leasing — Financial Issues Facing Landlords and Tenants Related to COVID-19

    ARTICLE / CLIENT ALERT

    Commercial Leasing — Financial Issues Facing Landlords and Tenants Related to COVID-19

    March 20, 2020

    Read time: 6 min

    Key takeaways
    Overview

    The COVID-19 pandemic has severely disrupted the daily lives of individuals and businesses across the United States as the federal and local governments continue to enact restrictions and preventative measures to stem the tide of infection.

    This Alert focuses on some of the financial issues facing landlords and tenants in the commercial lease context related to COVID-19, particularly as tenants begin seeking rent abatements and other concessions from landlords as a result of the inability to properly occupy, utilize and enjoy their business premises. Below are some of the approaches that tenants may explore as they look to landlords for rent relief.

    Express Contractual Rights

    Landlords and tenants should review their lease documents to determine their rights and obligations in light of the specific circumstances leading to the complete or partial discontinuation of business operations and use of the demised space. For example, “force majeure” clauses in commercial leases address improbable events beyond a party’s control, such as the outbreak of war, natural disasters or “acts of God,” that prevent a party from performing its obligations under an agreement. Generally speaking, courts have historically interpreted force majeure provisions narrowly on a case-by case basis and are more apt to excuse a party’s performance if the force majeure clause expressly lists the event that prevents a party’s performance. Therefore, leases should be reviewed to identify specific terms that would apply to the COVID-19 pandemic such as “epidemic,” “pandemic,” “contagious disease” or “public health emergency.” It is also important to note that even if a force majeure clause contemplates a pandemic or similar event, most force majeure clauses in commercial leases expressly exclude relief from rent payment obligations.

    Force majeure provisions may have specific application in particular types of contracts. For more information on some of these specific applications please see the following SRZ Alerts: Force Majeure Under New York and Delaware Law (March 19, 2020) (discussing force majeure and other aspects of contract law applying during the COVID-19 global pandemic); Real Estate Deals and Leases — COVID-19 Considerations (March 17, 2020) (discussing “go-dark” and material adverse effect provisions in leases and other real estate agreements); Trading Agreements — Buy-Side Considerations (COVID-19) (March 17, 2020) (discussing force majeure and related provisions in trading agreements, including ISDA master agreements, prime brokerage agreements, master repurchase agreements, futures agreements and FX master agreements); and Business Interruption and Related Insurance for Losses from COVID-19 (March 17, 2020) (outlining business interruption insurance and other insurance related to loss).

    Common Law Doctrine

    Tenants may seek to rely on the common law doctrine known as “frustration” as a way to gain financial relief. Frustration occurs when an unforeseen event either renders contractual obligations impossible or substantially frustrates a party’s principal purpose for entering into the contract. Given the rarity of pandemics in the United States, there is little legal precedent in connection with pandemic-related lease disputes so, in addition to potential lengthy and costly legal action, it is uncertain whether the COVID-19 outbreak and its adverse impacts would be enough to reach the threshold necessary for a successful frustration claim. However, if government officials take more stringent steps to prevent further spread of the COVID-19 virus (such as prolonged periods of mandated lockdown of citizens or building shutdowns), it is conceivable that courts could grant this unusual relief to tenants.

    Landlord Assistance

    As losses continue to mount for commercial tenants worldwide as a result of the COVID-19 outbreak, there has been some societal and governmental pressure on landlords to step in and offer financial assistance. Over the past several weeks, some of the largest landlords across Singapore, Hong Kong and Malaysia have responded by offering their retail tenants partial rent abatements of up to 50% for the next several months or, in some cases, for the period affected by COVID-19 government measures. As cities around the United States continue to grapple with potential enactments of further preventative measures that may continue to hinder tenants and their businesses, it remains to be seen whether some of the larger U.S. landlords will follow their international counterparts and proactively step in to offer their tenants some form of rent relief.

    Settlement Discussions

    While tenants may have limited contractual remedies in seeking rent relief under their leases, it would be prudent for landlords, including for the reasons discussed below, to maintain an open dialogue with their tenants in order to explore an acceptable outcome for each of the parties:

    • Legislation. Several U.S. cities are in the process of contemplating or passing legislation that would suspend the ability of landlords to evict commercial tenants for up to 12 months. While it remains to be seen whether additional tenant-friendly measures are considered by legislators, landlords would be wise to work with their tenants and come up with creative solutions that would provide some level of financial relief and at the same time allow their tenants to stay in possession on a long-term basis.
    • Replacement Tenants. Given the current impact of COVID-19 and the uncertainty of when businesses across many cities in the United States will be able to resume normal, healthy operations, even if a landlord were successful in evicting its tenant for failure to pay rent, the costs and potential difficulty for a landlord to procure a replacement tenant will likely prove to be quite challenging.

    While the ultimate adverse impact of COVID-19 on the U.S. real estate market remains to be seen, it is likely to be material in the short term and the current legal restrictions and CDC guidelines have created a challenging environment for both landlords and tenants. Parties should look to avoid lengthy and costly legal action by searching for creative alternative solutions that can benefit both parties in the long term.

    Authored by Aaron Schwed and Julian M. Wise.

    If you have any questions concerning this Alert, please contact your attorney at Schulte Roth & Zabel or one of the authors.


    This communication is issued by Schulte Roth & Zabel LLP for informational purposes only and does not constitute legal advice or establish an attorney-client relationship. In some jurisdictions, this publication may be considered attorney advertising. ©2020 Schulte Roth & Zabel LLP.

    All rights reserved. SCHULTE ROTH & ZABEL is the registered trademark of Schulte Roth & Zabel LLP.

    In depth
    Authors

    Julian M. Wise

    Partner

    New York – 919 Third Avenue

    More insights

  • Lenders and Other Dealmakers: Update on US Patent and Trademark Office and Copyright Office Closures

    Lenders and Other Dealmakers: Update on US Patent and Trademark Office and Copyright Office Closures

    ARTICLE / CLIENT ALERT

    Lenders and Other Dealmakers: Update on US Patent and Trademark Office and Copyright Office Closures

    March 20, 2020

    Read time: 4 min

    Key takeaways
    Overview

    Lenders, private equity sponsors and other dealmakers routinely make filings with the U.S. Patent and Trademark Office (“USPTO”) and the U.S. Copyright Office (“USCO”) to protect their valuable rights in patents, trademarks and copyrights. Amidst the COVID-19 pandemic, the USCO and USPTO have closed their doors. While neither office has extended the statutory deadlines for making filings, and processing delays are expected, both offices continue to maintain their electronic filing systems and have adopted procedures such that lenders and other dealmakers can make filings to timely record documents establishing or evidencing their rights during these closures.

    US Patent and Trademark Office

    The USPTO continues to accept nearly all filings, including security interest grants, assignments, new applications and documents necessary to renew and maintain trademarks and patents, through its website.[1] The USPTO has also communicated that staff will continue to process these filings through telework.[2] Thus, while processing delays are expected, the USPTO’s closure should not substantively impact the ability to obtain and record rights in trademarks and patents through electronic filings.

    US Copyright Office

    Due to the closure, the USCO is not accepting filings made in person or by private courier.[3] This impacts the filing of security interests and other assignments, as these filings cannot be made electronically. However, the USCO has communicated to us and our service providers that it will accept these filings by mail (U.S. postal service or commercial express carrier, such as UPS or FedEx), and that the delivery date (the date that the USCO receives the filing, whether or not USCO staff has been able to log it in) will be considered the filing date. The USCO also continues to accept applications to register new copyrights through its website and is discouraging applicants from filing paper copies. Thus, while the already lengthy delay at the USCO in processing filings will likely become even longer, the USCO’s closure should not substantively impact the ability to  obtain and record rights in copyrightable works through filings made according to the revised procedures.

    Authored by Edward H. Sadtler, Scott M. Kareff and Jaclyn N. Malmed.

    If you have any questions concerning this Alert, please contact your attorney at Schulte Roth & Zabel or one of the authors.


    [1] The USPTO’s website contains detailed information on how the COVID-19 pandemic has impacted its operations and policies.

    [2] Additionally, the USPTO has announced that relief in the form of fee waivers for “petition to revive filings” will be available for missed filing deadlines if the applicant submits evidence that the delay in filing was due to the applicant being personally affected by the coronavirus outbreak; however, as no waivers or extensions are available for time periods established by statute, certain statutory rights may be irretrievably lost and the circumstances under which these measures will aid applicants may in practice be limited. View the USPTO’s official notice.

    [3] The USCO’s website contains detailed information on how the COVID-19 pandemic has impacted its operations and policies.


    This communication is issued by Schulte Roth & Zabel LLP for informational purposes only and does not constitute legal advice or establish an attorney-client relationship. In some jurisdictions, this publication may be considered attorney advertising. ©2020 Schulte Roth & Zabel LLP.

    All rights reserved. SCHULTE ROTH & ZABEL is the registered trademark of Schulte Roth & Zabel LLP.

    In depth
    Authors

    Scott M. Kareff

    Special Counsel

    New York – 919 Third Avenue

    More insights

  • COVID-19 Relief for Small Businesses: What’s Available?

    ARTICLE / CLIENT ALERT

    COVID-19 Relief for Small Businesses: What’s Available?

    March 19, 2020

    Read time: 5 min

    Key takeaways
    Overview

    In response to the Coronavirus (COVID-19) pandemic, the US government has undertaken significant action in recent weeks to offer relief to small businesses, which may be disproportionately affected by the pandemic and its fallout. This On the Subject provides a summary of the relief currently available to small businesses.

    In depth

    Small businesses may be uniquely affected by the Coronavirus (COVID-19) pandemic. Businesses with fewer than 500 employees accounted for 99.7% of US employer firms, according to the Census Bureau’s Annual Survey of Entrepreneurs from 2016. Of those companies with fewer than 500 employees, only half have a cash buffer large enough to support 27 days of their typical outflows, according to a 2016 study by the JP Morgan Chase Institute.

    In response to the urgent need for assistance, the federal government has undertaken significant action in the past weeks, including the following measures:

    1. Federal National Declaration of Emergency Under the Stafford Act

    On March 13, 2020, President Trump declared a national emergency under the Stafford Act, which frees up more than $40 billion in federal funds and gives the Federal Emergency Management Agency a greater role in COVID-19 response efforts. This declaration also gives the US Department of Health and Human Services Secretary greater authority and flexibility to respond to the crisis. In his announcement, the president highlighted waivers for limits on the provision of telemedicine, removal of timing and bed limits for certain hospitals, and limits on the use of facilities so that emergency capacities can be quickly established.

    2. Small Business Administration Economic Injury Disaster Loans

    On March 6, 2020, the president signed into law HR 6074, The Coronavirus Preparedness and Response Supplemental Appropriations Act of 2020 (Supplemental Appropriation).

    The $8.3 billion Supplemental Appropriation includes a provision that enables the Small Business Administration (SBA) to make an estimated $7 billion in low-cost loans to affected small business in the form of economic injury disaster loans (EIDLs). Affected small business owners can visit the SBA’s website for more information on how to apply for a disaster loan.

    EIDLs are available only after a state governor makes a disaster declaration pursuant to the Stafford Act and the president subsequently approves the declaration. Ordinarily, local, state and federal officials jointly make a preliminary damage assessment to assess the need for federal assistance.

    Once a state disaster declaration is approved, EIDLs offer up to $2 million in assistance per small business. The loans can be used to pay fixed debts, payroll, accounts payable and other bills that can’t be paid due to the disaster. The interest rate is 3.75% for businesses without credit available elsewhere (those with credit available elsewhere are not eligible) and 2.75% for nonprofits. SBA offers loans with long-term repayments, up to a maximum of 30 years.

    How do I know if my company qualifies as a small business?

    SBA measures small businesses on the basis of published size standards. Per the SBA, “A size standard, which is usually stated in number of employees or average annual receipts, represents the largest size that a business (including its subsidiaries and affiliates) may be to remain classified as a small business for SBA and federal contracting programs. The definition of ‘small’ varies by industry.”

    The question of how “subsidiaries and affiliates” are incorporated into the size standards is a material issue for subsidiaries of larger organizations or portfolio companies, and may require legal analysis in some cases. SBA offers a guide on the affiliation requirements.

    Does SBA require collateral for EIDLs?

    Yes. Generally SBA requires collateral for EIDLs over $5,000, but it will not reject an application if no collateral is available. EIDL assistance is available to small businesses only when SBA determines they are unable to obtain credit elsewhere.

    How do I apply for an EIDL?

    You can apply online for an SBA disaster assistance loan.

    How do I know if my area is eligible for EIDLs?

    EIDLs are only available in areas where a disaster declaration has been approved. Click here for a list of disaster declarations.

    3. Families First Coronavirus Response Act

    On March 18, 2020, the president signed into law HR 6201, the Families First Coronavirus Response Act. This legislation includes significant changes that particularly affect small businesses with fewer than 500 employees, including changes to:

    • Mandatory paid sick leave
    • Family Medical Leave Act provisions
    • Tax credits for employers.

    A detailed summary of HR 6201 and its employer-specific provisions can be found at our Coronavirus Resource Center.

    4. Additional Proposals

    In addition to the federal relief efforts detailed above, the Trump administration and congressional leadership have put forward proposals that include significant investments in small businesses, totaling hundreds of billions of dollars. It is too early to tell what specific relief will be made available, but small business interests will clearly be at the front and center of any legislative package proposed.

    Authors

    Peter M. Routh

    Associate

    Washington, DC

    More insights

  • Coronavirus FAQs for French Employers

    Coronavirus FAQs for French Employers

    ARTICLE

    Coronavirus FAQs for French Employers

    March 2020

    Read time: 1 min

    Key takeaways
    Overview

     

    In depth
    Authors

    Jilali Maazouz

    Partner

    Paris

    More insights

  • Trump Signs Families First Coronavirus Response Act

    Trump Signs Families First Coronavirus Response Act

    ARTICLE / CLIENT ALERT

    Trump Signs Families First Coronavirus Response Act

    March 19, 2020

    Read time: 3 min

    Key takeaways
    Overview

    President Trump signed into law on Wednesday night the Families First Coronavirus Response Act (the “Act”) following a 90-8 vote by the Senate earlier in the day. The Act provides paid sick leave to American workers affected by the Coronavirus (COVID-19) in a variety of ways.

    In depth

    President Trump signed into law on Wednesday night the Families First Coronavirus Response Act (the “Act”) following a 90-8 vote by the Senate earlier in the day. The Act provides paid sick leave to American workers affected by the Coronavirus (COVID-19) in a variety of ways.

    The Act includes the following important benefits effective not later than April 2, 2020:

    • An emergency paid sick leave benefits program for employees taking paid leave
    • A requirement for certain large employers to offer paid sick leave
    • A tax credit against payroll taxes for employers offering paid sick and paid family and medical leave
    • Expanded unemployment benefits for workers losing their jobs because of COVID-19
    • Grants to states to cover processing and paying claims

    The Act provides for COVID-19 diagnostic testing at no cost to consumers, makes personal respiratory protective devices eligible for certain liability protections, and temporarily increases the Medicaid federal medical assistance percentage (FMAP). It also includes emergency appropriations for select nutritional assistance programs, suspends the work requirements for the Supplemental Nutrition Assistance Program (SNAP), permits states to request waivers to provide emergency SNAP benefits, and relaxes requirements for the school meals program.

    Policymakers are considering additional economic stimulus measures, and there is cautious optimism that additional legislation will be enacted shortly to help avert economic hardships that are arising due to business shutdowns. A Treasury memo proposes a $1 trillion stimulus and relief package, including direct cash payments to individuals, targeted secured lending for especially impacted industries such as airlines, small business interruption loan guarantees, and the use of the Exchange Stabilization Fund to guarantee money market mutual funds. A group of Democratic senators led by Cory Booker (NJ), Michael Bennet (CO) and Sherrod Brown (OH) proposed immediate cash payments of $2,000 per adult and child, subject to a phase-out for high-income taxpayers, with automatic quarterly follow-on payments triggered by macroeconomic performance.

    Authors

    Andrew C. Liazos

    Partner

    Boston, New York – One Vanderbilt Avenue

    More insights